Premium
EFFICACY OF GEFITINIB AND ERLOTINIB IN INDONESIAN PATIENTS WITH LUNG ADENOCARCINOMA WITH ACTIVATING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS
Author(s) -
Ungky Agus Setyawan,
Hana Khairina,
Putri Faisal,
Shoko Hirano,
Fumiko Irisuna,
Yasushi Horimasu,
Jamal Zaini,
Faisal Yunus,
Noboru Hattori,
Eiso Hiyama
Publication year - 2019
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13699_154
Subject(s) - gefitinib , erlotinib , medicine , epidermal growth factor receptor , adenocarcinoma , lung cancer , oncology , epidermal growth factor , lung , indonesian , cancer research , receptor , cancer , linguistics , philosophy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom